Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials
2014 · BMC Medicine · 84 citations
https://doi.org/10.1186/s12916-014-0132-3
P
Pernelle Lavaud
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
321
Papers
1.4K
Citations
19
h-index
35
i10-index
Pernelle Lavaud is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer Genomics and Diagnostics & Cancer, Lipids, and Metabolism. The author has an h-index of 19, co-authored 273 publications.
ORCID: 0000-0002-1286-5955Papers by this author
worksCirculating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
2021 · npj Precision Oncology · 28 citations
https://doi.org/10.1038/s41698-021-00203-1
The genomic and transcriptomic landscape of metastastic urothelial cancer
2024 · Nature Communications · 16 citations
https://doi.org/10.1038/s41467-024-52915-0
Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis
2016 · Breast Cancer Research and Treatment · 13 citations
https://doi.org/10.1007/s10549-016-3798-8
Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer
2023 · Clinical and Translational Radiation Oncology · 4 citations
https://doi.org/10.1016/j.ctro.2023.100637
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
2024 · JTO Clinical and Research Reports · 1 citations
https://doi.org/10.1016/j.jtocrr.2024.100773
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat